切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2026, Vol. 22 ›› Issue (03) : 259 -266. doi: 10.3877/cma.j.issn.1673-5250.2026.03.009

论著

复发性子宫内膜异位症恶变为阴道残端腺肉瘤1例并文献复习
晏和春, 朱仲毅, 李林, 何跃东()   
  1. 四川大学华西第二医院妇产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2026-04-22 修回日期:2026-05-15 出版日期:2026-06-01
  • 通信作者: 何跃东

Vaginal stump adenosarcoma arising in recurrent endometriosis: a case report and literature review

Hechun Yan, Zhongyi Zhu, Lin Li, Yuedong He()   

  1. Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2026-04-22 Revised:2026-05-15 Published:2026-06-01
  • Corresponding author: Yuedong He
  • Supported by:
    2021 Tianfu Qingcheng Plan-Tianfu Famous Physician Project of Sichuan Provincial Committee(Chuan Qingcheng 903); Key R&D Project of Sichuan Provincial Science and Technology Department(2024YFFK0327); Youth Medical Research Innovation Project of Sichuan Medical Association(Q21009)
引用本文:

晏和春, 朱仲毅, 李林, 何跃东. 复发性子宫内膜异位症恶变为阴道残端腺肉瘤1例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2026, 22(03): 259-266.

Hechun Yan, Zhongyi Zhu, Lin Li, Yuedong He. Vaginal stump adenosarcoma arising in recurrent endometriosis: a case report and literature review[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2026, 22(03): 259-266.

目的

探讨复发性子宫内膜异位症(EMS)恶变为阴道残端腺肉瘤患者的临床表现、诊断及治疗方法。

方法

选择2024年12月于四川大学华西第二医院诊治的1例复发性EMS恶变为阴道残端腺肉瘤患者(患者1)为研究对象。采用回顾性分析方法,分析其临床病例资料,包括病史、临床表现、影像学检查结果、病理学特征、治疗及随访结果等。以"adenosarcoma""vaginal stump""endometriosis"等为中、英文关键词,检索中国知网数据库、万方数据知识服务平台及维普中文期刊服务平台与PubMed、Web of Science(WoS)中关于EMS恶变为阴道残端腺肉瘤的相关文献,并对该类患者的病史、临床表现、影像学检查结果、病理学特征、治疗及随访结果进行综合分析。本研究遵循的程序符合四川大学华西第二医院伦理委员会制定的标准,并获得该伦理委员会批准[审批文号:2025(315)]。

结果

①患者1为复发性EMS恶变为阴道残端腺肉瘤患者,51岁,G3P1,因"发现阴道残端包块1年"于2024年12月18日在本院妇科就诊。患者1既往有EMS病史,本次因阴道残端包块逐渐增大,并伴阴道出血收入本院治疗。入院前,其盆腔MRI检查结果提示阴道残端及左侧盆腔多发结节、团块影;糖类抗原(CA)125及CA19-9水平均升高,阴道残端病灶组织穿刺活检未提示明确恶性病变。本次入院后,对其进行经腹阴道残端病灶切除术的术后组织病理学检查证实为息肉样EMS恶变为腺肉瘤,肉瘤成分含子宫内膜间质肉瘤及横纹肌肉瘤。术后对其盆腔外照射联合6个周期化疗,末次化疗后7个月时未见肿瘤残留或复发。②文献复习结果:采用本研究设定文献检索策略,共检索到关于EMS恶变为阴道残端腺肉瘤患者相关研究文献为7篇,加上患者1,本研究共计纳入8例该病患者,对其病史、临床表现、影像学检查结果、病理学特征、治疗及随访结果进行综合分析如下。这8例患者的中位年龄为48.5岁,临床表现以阴道出血为主(患者1~3、5),盆腔肿物为3例(患者6~8),尿失禁及阴道肿物脱垂为1例(患者4)。3例(患者1、5、8)肉瘤成分存在异源性分化,2例(患者2、3)存在肉瘤成分过度生长。这8例患者均接受手术治疗,1例(患者2)腺肉瘤复发后死亡,3例(患者5、6、8)腺肉瘤复发后经过治疗获得缓解,另外4例(患者1、3、4、7)初次治疗后在随访期内均未复发。

结论

EMS恶变致阴道残端腺肉瘤患者临床较为罕见,临床及影像学表现缺乏特异性,确诊需依赖组织病理学检查。手术为主要治疗方式,术后辅助放疗和(或)化疗需结合病理学特征及个体情况综合决定。

Objective

To explore the clinical manifestations, diagnosis, and treatment of recurrent endometriosis (EMS) that has undergone malignant transformation into vaginal stump adenosarcoma.

Methods

A patient with vaginal stump adenosarcoma arising from recurrent EMS, who was treated at West China Second University Hospital, Sichuan University, in December 2024 (patient 1), was selected into this study. A retrospective analysis of the patient′s clinical records was conducted, including medical history, clinical presentation, imaging findings, pathological characteristics, treatment, and follow-up results. Using Chinese and English keywords such as " adenosarcoma" " vaginal stump" and " endometriosis", we searched the CNKI, Wanfang, and VIP databases, as well as PubMed and Web of Science (WoS), for relevant literature on the malignant transformation of endometriosis into vaginal stump adenosarcoma, and conducted a comprehensive analysis of the medical history, clinical manifestations, imaging findings, pathological characteristics, treatment, and follow-up outcomes of these patients. The procedures followed in this study complied with the standards set by the Ethics Committee of West China Second University Hospital, Sichuan University, and were approved by the Ethics Committee [Approval No.2025(315)].

Results

① Patient 1, a 51-year-old woman (G3P1), presented to the Gynecology Department of our hospital on December 18, 2024, with a chief complaint of " a mass at the vaginal stump discovered over a year ago". Patient 1 has a history of EMS and was admitted to our hospital due to a gradually enlarging mass at the vaginal stump accompanied by vaginal bleeding. A pelvic MRI performed prior to admission revealed multiple nodular and mass-like lesions in the vaginal stump and the left pelvis. Elevated levels of carbohydrate antigens (CA) 125 and CA19-9 were observed; however, a needle biopsy of the vaginal stump lesion did not reveal any definitive evidence of malignancy. Following admission, the patient underwent resection of the vaginal stump lesion by laparotomy. Postoperative pathological examination confirmed that the polypoid EMS had undergone malignant transformation into adenosarcoma, with the sarcomatous component consisting of endometrial stromal sarcoma and rhabdomyosarcoma. Postoperatively, the patient received pelvic external beam radiation therapy combined with six cycles of chemotherapy. Seven months after the last cycle of chemotherapy, no residual tumor or recurrence was observed. ②Literature review results: Using the literature search strategy established in this study, a total of 7 research articles related to the malignant transformation of EMS into vaginal stump adenosarcoma were identified. Including patient 1, a total of 8 relevant patients were included in the study. A comprehensive analysis of their medical histories, clinical presentations, imaging findings, pathological characteristics, treatment, and follow-up results is presented below.The median age of these 8 patients was 48.5 years old. The primary clinical manifestation was vaginal bleeding (patients 1-3, and 5); pelvic masses were present in 3 cases (patients 6-8); and urinary incontinence and vaginal mass prolapse were present in 1 case (patient 4). In addition, three cases (patients 1, 5, and 8) exhibited heterotopic differentiation of the sarcomatous component, and two cases (patients 2 and 3) showed overgrowth of the sarcomatous component. All 8 patients underwent surgical treatment. One patient (patient 2) died following a recurrence; 3 patients (patients 5, 6, and 8) achieved remission following treatment after recurrence; and the remaining 4 patients (patients 1, 3, 4, and 7) did not experience recurrence during the follow-up period after their initial treatment.

Conclusions

Vaginal stump adenosarcoma arising from the malignant transformation of EMS is a relatively rare clinical condition, and lacks specific clinical and imaging features. Definitive diagnosis mainly relies on histopathological examination. Surgical resection remains the primary treatment, and the decision to administer adjuvant radiation therapy and/or chemotherapy after surgery should be made based on a comprehensive assessment of pathological characteristics and individual patient circumstances.

图2 患者1(女性,51岁)阴道残端包块病理切片组织的染色图(黑色箭头所示为腺体周围明显增生的间质细胞,黑色椭圆所示为致密间质细胞包围腺体,形成"袖套样"结构,HE染色,低倍)
表1 8例EMS恶变为阴道残端腺肉瘤患者的临床资料比较
患者编号 文献(第1作者,发表年) 年龄(岁) 生育史(分娩方式)/临床表现 EMS病史(年) 肉瘤异源性成分/肉瘤过度生长 治疗方案 随访及患者结局
1 本研究 51 G3P1(阴道分娩)/阴道残端包块、阴道出血 2 横纹肌肉瘤/否 经腹阴道残端病灶切除术,术后盆腔外照射治疗联合6个周期静脉化疗 末次化疗后7个月未见肿瘤残留或复发;存活
2 Toyoshima[15],2004 52 G1P1(未提及)/阴道出血 10 无/是 新辅助化疗后经腹阴道残端病灶、阴道壁、大网膜切除术,术后进行3个周期静脉化疗 术后6个月复发,术后9个月死亡
3 Pontrelli[5],2016 58 未提及/阴道出血 19 无/是 腹腔镜下全阴道切除术,术后使用孕激素治疗 术后未见肿瘤残留或复发;存活a
4 Liu[13],2003 56 G0P0/尿失禁、阴道肿物脱垂 2 无/否 经腹阴道残端病灶、直肠、部分膀胱壁、淋巴结切除术,术后盆腔放射治疗联合化疗 术后未见肿瘤残留或复发;存活a
5 Judson[12],2000 42 G0P0/阴道出血、腹痛 4 脂肪成分/否 经腹阴道残端病灶切除术,术后进行6个周期化疗并口服他莫昔芬治疗 术后1年复发,进行盆腔放疗后未见复发;存活
6 Han[14],2010 34 G0P0/盆腔肿物 4 无/否 阴道残端病灶切除术,术后进行3个周期化疗 术后复发1次(时间不详),手术切除病灶后进行8个周期化疗,并口服依托泊苷维持治疗,未见再次复发;存活
7 Anderson[16],2001 46 多产(具体不详)/盆腔肿物 4 无/否 经腹阴道残端病灶、阴道旁组织切除术,术后进行盆腔放射治疗 术后未见肿瘤残留、复发;存活a
8 邓志娟[11],2010 34 G0P0/盆腔肿物 3 肌源性成分/否 阴道残端病灶切除术 于术后第8、12个月各复发1次,均进行手术切除病灶;存活
[1]
Kuramoto J, Matsubara C, Sasamoto Y, et al. Cytological characteristics of Müllerian adenosarcoma of the uterine corpus: a case report and literature review [J]. J Pathol Transl Med, 2025, 59(5): 340-347. DOI: 10.4132/jptm.2025.08.11.
[2]
Huang P, Chang W, Huang S. Mullerian adenosarcoma: a review of cases and literature [J]. Eur J Gynaecol Oncol, 2014, 35(6): 617-620.
[3]
Masand RP, Euscher ED, Deavers MT, et al. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases [J]. Am J Surg Pathol, 201337(11): 1635-1647. DOI: 10.1097/PAS.0000000000000083.
[4]
McCluggage WG. Mullerian adenosarcoma of the female genital tract [J]. Adv Anat Pathol, 2010, 17(2): 122-129. DOI: 10.1097/PAP.0b013e3181cfe732.
[5]
Pontrelli G, Cozzolino M, Stepniewska A, et al. Primary vaginal adenosarcoma with sarcomatous overgrowth arising in recurrent endometriosis: feasibility of laparoscopic treatment and review of the literature [J]. J Minim Invasive Gynecol, 2016, 23(5): 833-838. DOI: 10.1016/j.jmig.2016.03.019.
[6]
Cozzolino M, Nasioudis D, Sisti G, et al. Malignant transformation of vaginal endometriosis-a review of literature [J]. Gynecol Obstet Invest, 2017, 82(2): 105-112. DOI: 10.1159/000449198.
[7]
Wang H, Chen C, Wang D, et al. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer [J]. BMC Cancer, 2023, 23(1): 1210. DOI: 10.1186/s12885-023-11641-4.
[8]
Czernobilsky B, Hohlweg-Majert P, Dallenbach-Hellweg G. Uterine adenosarcoma: a clinicopathologic study of 11 cases with a reevaluation of histologic criteria [J]. Arch Gynecol, 1983, 233(4): 281-294. DOI: 10.1007/BF02133803.
[9]
Clement P, Scully R. Mullerian adenosarcoma of uterus-clinicopathologic analysis of 10 cases of a distinctive type of mullerian mixed tumor [J]. Cancer, 1974, 34(4): 1138-1149.
[10]
Parker RL, Dadmanesh F, Young RH, et al. Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature [J]. Am J Surg Pathol, 2004, 28(3): 285-297. DOI: 10.1097/00000478-200403000-00001.
[11]
邓志娟,郭丽娜. 难治性子宫内膜异位症恶变为阴道腺肉瘤1例报道 [J].诊断病理学杂志2010, 17(2): 148-149. DOI: 10.3969/j.issn.1007-8096.2010.02.023.
[12]
Judson PL, Temple AM, Fowler WC, et al. Vaginal adenosarcoma arising from endometriosis [J]. Gynecol Oncol, 200076(1): 123-125. DOI: 10.1006/gyno.1999.5617.
[13]
Liu L, Davidson S, Singh M. Müllerian adenosarcoma of vagina arising in persistent endometriosis: report of a case and review of the literature [J]. Gynecol Oncol, 200390(2): 486-490. DOI: 10.1016/s0090-8258(03)00266-x.
[14]
Han X, Leng J, Guo L, et al. Vaginal adenosarcoma arising from refractory endometriosis: a case report [J]. Aust N Z J Obstet Gynaecol, 201050(6): 574-576. DOI: 10.1111/j.1479-828X.2010.01213.x.
[15]
Toyoshima M, Akahira J, Moriya T, et al. Primary vaginal adenosarcoma with sarcomatous overgrowth [J]. Gynecol Oncol, 200495(3): 759-761. DOI: 10.1016/j.ygyno.2004.08.004.
[16]
Anderson J, Behbakht K, De Geest K, et al. Adenosarcoma in a patient with vaginal endometriosis [J]. Obstet Gynecol, 200198(5 Pt 2): 964-966. DOI: 10.1016/s0029-7844(01)01545-9.
[17]
Omi M, Tonooka A, Chiba T, et al. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases [J]. Diagn Pathol, 202015(1): 119. DOI: 10.1186/s13000-020-01036-5.
[18]
Korman SE, Vissers G, Gorris M, et al. Artificial intelligence-based tissue segmentation and cell identification in multiplex-stained histological endometriosis sections [J]. Hum Reprod, 202540(3): 450-460. DOI: 10.1093/humrep/deae267.
[19]
Mandato VD, Torricelli F, Mastrofilippo V, et al. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review [J]. BMC Cancer, 2018, 18(1): 134. DOI: 10.1186/s12885-018-4037-y.
[20]
Seagle BL, Kanis M, Strohl AE, et al. Survival of women with Mullerian adenosarcoma: a national cancer data base study [J]. Gynecol Oncol, 2016, 143(3): 636-641. DOI: 10.1016/j.ygyno.2016.10.013.
[1] 王硕, 郑新宇. 乳腺癌术后同侧乳腺肿瘤复发的病理学认知与处理[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(03): 133-137.
[2] 李志超, 叶梓绎, 辛万鹏. TACE在肝细胞癌根治性切除术后MVI阳性患者的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 252-256.
[3] 赵军抗, 张前进, 庄惠杰. 腹腔镜直肠癌根治术保留左结肠动脉的疗效及对预后的影响[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 257-260.
[4] 夏天, 肖恒军, 冯泽佳, 罗杰珩, 崔宇斌, 王华, 李腾成, 狄金明. 以持续性血精为首发症状的原发性精囊腺癌一例报告并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 346-351.
[5] 傅晓键, 黄先觉, 储宇霄, 朱志远, 姚琪远, 花荣. 腹腔镜合成补片修补Ⅲ型食管裂孔疝的中期疗效分析:单中心回顾性研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(03): 284-288.
[6] 郑宇, 邱少凡, 宋春义, 张翔宇, 王佳, 马少卫. 不同腹腔镜手术对老年男性复发性腹股沟疝的效果研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(03): 307-312.
[7] 王书翰, 任振, 刘虎, 吴昊, 潘晨, 吴立胜. 腹腔镜Sugarbaker技术修补造口旁疝关键细节优化及近远期并发症处理分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(02): 142-148.
[8] 王海波, 王守练, 潘春鹏, 倪晓春, 张弛豪, 俞继卫. 腹腔镜造口旁疝IPST和Sugarbaker修补术的疗效比较[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(02): 89-93.
[9] 孙丹, 卢柔霏, 林汇斯. 单孔腹腔镜在直肠阴道隔子宫内膜异位症切除中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(02): 118-121.
[10] 姜海珍, 江煜焓, 张丹, 陈晨晨. 骨髓间充质干细胞外泌体调控TLR4/NF-κB信号通路缓解小鼠子宫内膜异位症研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(03): 140-149.
[11] 叶金宝, 梁声强, 马建新, 林小强, 张海森. 小野寺预后营养指数对肝癌复发预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 372-378.
[12] 张文华, 陈宇凡, 林松茸, 江艺, 江哲龙. 肝癌肿瘤出芽与患者临床病理特征关系及其对切除术后复发影响[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 386-391.
[13] 杨宁, 张立翱, 李仁君, 金水. 非遗传性结直肠息肉病患者的临床特征及息肉复发的影响因素分析[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(02): 168-174.
[14] 张婧萱, 郭佳星, 李紫红, 陈怡颖, 乔媛, 宝莹娜. 多线治疗失败后31例复发转移性结直肠癌局部挽救性放射治疗的研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(03): 206-211.
[15] 韩一梅, 冯仕川, 陈志娟. 高脂血症性急性胰腺炎复发的危险因素及其列线图预测模型构建[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(03): 222-228.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?